Moringa oleifera extract inactivates nuclear transcription factor nuclear factor-kappa B p65/50 subunits and inhibits expression of tumor necrosis factor-α, interleukin-6, and interleukin-8 in phorbol 12-myristate 13-acetate-stimulated human breast cancer cells
International Journal of Health Sciences · 2025
DOI: 10.25259/ijhs_8871 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Health Sciences, 2025. Verfasst von Rashid Mumtaz Khan. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study investigated the potential anti-inflammatory effects of Moringa oleifera extract (ME) against phorbol 12-myristate 13-acetate (PMA) stimulation of nuclear transcription factor nuclear factor-kappa B (NF-κB) p65/50, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-8 (IL-8) in human breast cancer cells.
Methods
Breast cancer cell lines (MCF-7) were treated with varying concentrations of ME before PMA stimulation. Cytokine messenger RNA (mRNA) expression was quantified using real-time polymerase chain reaction, and protein levels of IL-6, TNF-α, and IL-8 were assessed through enzyme-linked immunosorbent assay. Cytotoxicity of the extract was evaluated using the Cell Titer-Glo Luminescent Cell Viability Assay kit to ensure that non-toxic concentrations were applied. The involvement of NF-κB signaling pathways was examined using the specific pathway inhibitor Bay-11-7082 and NF-κB p65 and p50-specific transcription kit.
Results
ME exhibited no cytotoxic effects on MCF-7 cells at effective concentrations (up to 40 µg/mL), highlighting its potential safety in therapeutic applications. ME significantly reduced the PMA-stimulated expression of TNF-α, IL-6, and IL-8 in a dose-dependent manner ( P < 0.05) at both mRNA and protein levels in MCF-7 cells. The data also demonstrated that ME deactivates PMA-induced NF-κB p65 and p50 activity. These findings collectively demonstrate that ME inhibits PMA-induced expression of TNF-α, IL-6, and IL-8 through deactivation NF-κB (p65/p50) pathways in breast cancer cells.
Conclusion
ME demonstrates potent anti-inflammatory properties in human breast cancer cells by downregulating key cytokines associated with tumor progression and inflammation. These findings suggest that ME could serve as a complementary approach in breast cancer therapy, targeting inflammatory pathways to mitigate tumor-associated inflammation and progression. Further research is warranted to elucidate the underlying mechanisms and in vivo efficacy.
Zitieren
APA
Khan, R. M. (2025). Moringa oleifera extract inactivates nuclear transcription factor nuclear factor-kappa B p65/50 subunits and inhibits expression of tumor necrosis factor-α, interleukin-6, and interleukin-8 in phorbol 12-myristate 13-acetate-stimulated human breast cancer cells. International Journal of Health Sciences. https://doi.org/10.25259/ijhs_8871
Vancouver
Khan RM. Moringa oleifera extract inactivates nuclear transcription factor nuclear factor-kappa B p65/50 subunits and inhibits expression of tumor necrosis factor-α, interleukin-6, and interleukin-8 in phorbol 12-myristate 13-acetate-stimulated human breast cancer cells. International Journal of Health Sciences. 2025. doi:10.25259/ijhs_8871
BibTeX
@article{Khan2025,
author = {Khan, Rashid Mumtaz},
title = {Moringa oleifera extract inactivates nuclear transcription factor nuclear factor-kappa B p65/50 subunits and inhibits expression of tumor necrosis factor-α, interleukin-6, and interleukin-8 in phorbol 12-myristate 13-acetate-stimulated human breast cancer cells},
journal = {International Journal of Health Sciences},
year = {2025},
doi = {10.25259/ijhs_8871}
}
EUVIMED